ABBV
ABBVIE INC
Health Care·Biotechnology·UNITED STATES
$261.83
MCap $462.7B
as of 2026-08-20
Total
B8w
Fund
C3w
Quant
A8w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
+0.18
Sentiment 29.5%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$261.83
Adaptive Mean
$260.61
+1.22 vs mean
Adaptive σ
3.30
MIDOS BB
$254.02 – $267.20
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.23
ROE
—
Z +1.75
Rev Gr
10.2%
Z -0.20
EPS Gr
290.4%
Z -0.08
OPM Gr
2.5%
Z -0.39
FCF Yld
3.6%
Z +0.38
EPS Surp
0.0%
Z -0.07
EPS 3mo Δ
106.5%
Z +0.19
Fwd P/E
16.13
Z —
PEGY
0.03
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
18.72
Q6M
7.61
Q12M
6.01
MA 30/100
1.107
Bullish (MA30 > MA100)
α (Jensen)
0.9301
β (12M)
-0.05
σ (12M)
0.264
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
81%
Q Percentile
82%
Divergence
-1.4
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
1.9
RS Pctl
64%
RS Decile
D7
Persistence
8w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.